CID Alvimedica is a world-class innovator in the field of interventional cardiology and cardiovascular surgery. Driven by the ambition to revolutionize cardiovascular care, the firm specializes in developing cutting-edge medical devices that address the most complex clinical challenges. The firm is renowned for its Cre8™ family of Polymer-free Drug Eluting Stents (DES) and advanced heart valve technologies. CID distinguishes itself by embedding exclusive, proprietary technologies—such as its unique Abluminal Reservoir and Bio-Inductor coatings—that push the boundaries of medical science. Their mission is to empower healthcare professionals with high-precision tools that significantly improve patient outcomes and minimize long-term complications. With a dedicated team of specialists and a robust R&D pipeline, CID Alvimedica continues to pave the way for the future of cardiovascular medicine, ensuring that "Made in Italy" engineering excellence reaches hospitals and patients globally.